These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

515 related articles for article (PubMed ID: 26823845)

  • 1. Prognostic value of ERCC1 and ERCC2 gene polymorphisms in patients with gastric cancer receiving platinum-based chemotherapy.
    Mo J; Luo M; Cui J; Zhou S
    Int J Clin Exp Pathol; 2015; 8(11):15065-71. PubMed ID: 26823845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic variability of genes in NER pathway influences the treatment outcome of gastric cancer.
    Xue MH; Li GY; Wu XJ; Zhang CX; Zhang CF; Zhu KX
    Int J Clin Exp Pathol; 2015; 8(5):5563-9. PubMed ID: 26191265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic variability of DNA repair mechanisms influences chemotherapy outcome of gastric cancer.
    Yu H; Wu X; Zhang Y; Jin Z; Li G; Zhao H
    Int J Clin Exp Pathol; 2015; 8(4):4106-12. PubMed ID: 26097599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic variability of ERCC1 and ERCC2 genes involved in the nucleotide excision repair pathway influences the treatment outcome of gastric cancer.
    Zheng DL; Tang GD; Chen YN; Zhang T; Qin MB
    Genet Mol Res; 2016 Apr; 15(2):. PubMed ID: 27173253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic polymorphisms of DNA repair pathways influence the response to chemotherapy and overall survival of gastric cancer.
    Zhou J; Liu ZY; Li CB; Gao S; Ding LH; Wu XL; Wang ZY
    Tumour Biol; 2015 Apr; 36(4):3017-23. PubMed ID: 25542228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic variability of ERCC1 and ERCC2 influences treatment outcomes in gastric cancer.
    Yu WH; Wang YX; Guo JQ; Wang YL; Zheng JS; Zhu KX
    Genet Mol Res; 2015 Dec; 14(4):17529-35. PubMed ID: 26782397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ERCC1 and ERCC2 variants predict survival in gastric cancer patients.
    Li Y; Liu Z; Liu H; Wang LE; Tan D; Ajani JA; Wei QY
    PLoS One; 2013; 8(9):e71994. PubMed ID: 24023723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic variability of DNA repair mechanisms in chemotherapy treatment outcome of gastric cancer patients.
    Zhong G; Li HK; Shan T; Zhang N
    Genet Mol Res; 2015 Dec; 14(4):17228-34. PubMed ID: 26681216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic variability of ERCC1 genes in NER pathway influences the treatment outcome of gastric cancer.
    Bai Y; Wang L; Li G; Fang X; Li Y; Yang S
    Int J Clin Exp Pathol; 2015; 8(10):13367-73. PubMed ID: 26722542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of ERCC1 and ERCC2 gene polymorphisms and response to chemotherapy and overall survival in osteosarcoma.
    Zhang Q; Lv LY; Li BJ; Zhang J; Wei F
    Genet Mol Res; 2015 Sep; 14(3):11235-41. PubMed ID: 26400354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation on the DNA repaired gene polymorphisms and response to chemotherapy and overall survival of osteosarcoma.
    Ji WP; He NB
    Int J Clin Exp Pathol; 2015; 8(1):894-9. PubMed ID: 25755792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic polymorphisms in nucleotide excision repair pathway influences response to chemotherapy and overall survival in osteosarcoma.
    Sun Y; Wu Y; Li W; Kong Z; Zou X
    Int J Clin Exp Pathol; 2015; 8(7):7905-12. PubMed ID: 26339355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between ERCC1 and ERCC2 gene polymorphisms and chemotherapy response and overall survival in osteosarcoma.
    Cao ZH; Yin HP; Jiang N; Yu B
    Genet Mol Res; 2015 Aug; 14(3):10145-51. PubMed ID: 26345951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphisms in ERCC1 and XPF gene and response to chemotherapy and overall survival of non-small cell lung cancer.
    Shi ZH; Shi GY; Liu LG
    Int J Clin Exp Pathol; 2015; 8(3):3132-7. PubMed ID: 26045829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between ERCC1 and ERCC2 gene polymorphisms and susceptibility to pancreatic cancer.
    He MG; Zheng K; Tan D; Wang ZX
    Genet Mol Res; 2016 Mar; 15(1):. PubMed ID: 27051038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of single nucleotide polymorphisms of DNA repair genes in NER pathway and susceptibility to pancreatic cancer.
    Zhao F; Shang Y; Zeng C; Gao D; Li K
    Int J Clin Exp Pathol; 2015; 8(9):11579-86. PubMed ID: 26617894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of ERCC1 and ERCC2 gene polymorphysims on response to cisplatin based therapy in osteosarcoma patients.
    Obiedat H; Alrabadi N; Sultan E; Al Shatti M; Zihlif M
    BMC Med Genet; 2018 Jul; 19(1):112. PubMed ID: 29980176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Polymorphisms of ERCC1 gene and outcomes in epithelial ovarian cancer patients with platinum-based chemotherapy].
    Qi BL; Li Y; Wang N; Zhou RM; Hu P; Kang S
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):847-52. PubMed ID: 24444563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigating the Frequency of the ERCC1 Gene C8092A Polymorphism in Iranian Patients with Advanced Gastric Cancer Receiving Platinum-based Chemotherapy.
    Mokmeli S; Tehrani GA; Zamiri RE; Bahrami T
    Asian Pac J Cancer Prev; 2016; 17(3):1369-72. PubMed ID: 27039774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacogenetics of platinum-based chemotherapy: impact of DNA repair and folate metabolism gene polymorphisms on prognosis of non-small cell lung cancer patients.
    Pérez-Ramírez C; Cañadas-Garre M; Alnatsha A; Villar E; Valdivia-Bautista J; Faus-Dáder MJ; Calleja-Hernández MÁ
    Pharmacogenomics J; 2019 Apr; 19(2):164-177. PubMed ID: 29662106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.